The Latest Breaking News from Nasdaq

Upgrades

U.S. stocks traded higher this morning, following the release of several economic reports.

US Railway Companies, Unions Reach Tentative Agreement Averting Catastrophic Strike

Gainers NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) rose 54.6% to $26.07 in pre-market trading after the company entered into an exclusive license agreement with Dong-A.

The U.S. index futures point to a modestly lower open on Wall Street on Thursday, with the mood reflecting indecision among traders ahead of the key U.S. retail sales report.

Gainers AMTD Digital Inc. (NYSE: HKD) shares jumped 311.8% to settle at $189.42 on Wednesday as the stock experienced a resurgence in momentum despite a lack of fundamental news.

Pre-open movers U.S. stock futures traded mostly flat in early pre-market trade on Thursday after closing higher on Wednesday. The Nasdaq 100 index gained around 100 points in the previous session after U.S. producer prices dropped for a second consecutive month in August.

The adoption of electric vehicles is progressing at a faster-than-expected rate, given automakers’ thrust to EV transitioning, governments’ mandates to ban ICE vehicles, and huge capital infusion into the space sector, an analyst at Needham said in a note.

Hong Kong stocks opened mixed on Thursday morning, with the benchmark Hang Seng gaining 0.38%, while EV stocks declined. Shares of XPeng, Li Auto and Nio fell over 1%.

An ad-supported plan coming later this year from streaming platform Netflix Inc (NASDAQ: NFLX) could add additional subscribers and revenue. Here’s a look at just how many subscribers Netflix thinks it can add with its new plan.

The U.S. Food and Drug Administration (FDA) has granted fast track designation for the development of TRACON’s (NASDAQ:TCON) lead asset envafolimab (KN035) for patients with locally advanced, unresectable or metastatic undifferentiated pleomorphic sarcoma (UPS) and myxofibrosarcoma (MFS) who have progressed on one or two prior lines of chemotherapy. TRACON shares…